Barclays’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.86M | Buy |
518,147
+278,051
| +116% | +$2.61M | ﹤0.01% | 1649 |
|
|
2025
Q1 | $1.71M | Sell |
240,096
-71,536
| -23% | -$509K | ﹤0.01% | 2124 |
|
|
2024
Q4 | $3.63M | Buy |
311,632
+18,837
| +6% | +$220K | ﹤0.01% | 1820 |
|
|
2024
Q3 | $6.02M | Buy |
292,795
+89,422
| +44% | +$1.84M | ﹤0.01% | 1396 |
|
|
2024
Q2 | $4.55M | Buy |
203,373
+18,078
| +10% | +$405K | ﹤0.01% | 1236 |
|
|
2024
Q1 | $5.1M | Sell |
185,295
-166,035
| -47% | -$4.57M | ﹤0.01% | 1362 |
|
|
2023
Q4 | $10.7M | Buy |
351,330
+94,704
| +37% | +$2.89M | ﹤0.01% | 1019 |
|
|
2023
Q3 | $8.12M | Buy |
256,626
+33,558
| +15% | +$1.06M | 0.01% | 939 |
|
|
2023
Q2 | $9.1M | Sell |
223,068
-2,585
| -1% | -$105K | 0.01% | 937 |
|
|
2023
Q1 | $8.41M | Sell |
225,653
-34,214
| -13% | -$1.27M | ﹤0.01% | 870 |
|
|
2022
Q4 | $9.07M | Buy |
259,867
+75,296
| +41% | +$2.63M | ﹤0.01% | 862 |
|
|
2022
Q3 | $10.3M | Buy |
184,571
+77,673
| +73% | +$4.35M | 0.01% | 809 |
|
|
2022
Q2 | $5.53M | Buy |
106,898
+6,061
| +6% | +$314K | ﹤0.01% | 1056 |
|
|
2022
Q1 | $7.33M | Sell |
100,837
-37,922
| -27% | -$2.76M | 0.01% | 986 |
|
|
2021
Q4 | $16.4M | Buy |
138,759
+62,574
| +82% | +$7.4M | 0.01% | 732 |
|
|
2021
Q3 | $10.2M | Buy |
76,185
+35,823
| +89% | +$4.81M | ﹤0.01% | 908 |
|
|
2021
Q2 | $6.53M | Sell |
40,362
-52,505
| -57% | -$8.5M | ﹤0.01% | 1100 |
|
|
2021
Q1 | $7.45M | Buy |
92,867
+75,801
| +444% | +$6.08M | ﹤0.01% | 946 |
|
|
2020
Q4 | $928K | Sell |
17,066
-12,993
| -43% | -$707K | ﹤0.01% | 2010 |
|
|
2020
Q3 | $597K | Buy |
30,059
+22
| +0.1% | +$437 | ﹤0.01% | 2217 |
|
|
2020
Q2 | $632K | Buy |
30,037
+3,874
| +15% | +$81.5K | ﹤0.01% | 2204 |
|
|
2020
Q1 | $320K | Sell |
26,163
-19,364
| -43% | -$237K | ﹤0.01% | 2342 |
|
|
2019
Q4 | $668K | Buy |
45,527
+25,989
| +133% | +$381K | ﹤0.01% | 2531 |
|
|
2019
Q3 | $260K | Sell |
19,538
-5,706
| -23% | -$75.9K | ﹤0.01% | 2936 |
|
|
2019
Q2 | $413K | Buy |
25,244
+15,725
| +165% | +$257K | ﹤0.01% | 2822 |
|
|
2019
Q1 | $162K | Sell |
9,519
-5,768
| -38% | -$98.2K | ﹤0.01% | 3117 |
|
|
2018
Q4 | $209K | Sell |
15,287
-1,018
| -6% | -$13.9K | ﹤0.01% | 2700 |
|
|
2018
Q3 | $466K | Buy |
16,305
+8,839
| +118% | +$253K | ﹤0.01% | 2675 |
|
|
2018
Q2 | $205K | Sell |
7,466
-12,312
| -62% | -$338K | ﹤0.01% | 2740 |
|
|
2018
Q1 | $416K | Buy |
19,778
+10,483
| +113% | +$220K | ﹤0.01% | 2411 |
|
|
2017
Q4 | $179K | Buy |
9,295
+2,367
| +34% | +$45.6K | ﹤0.01% | 2709 |
|
|
2017
Q3 | $172K | Buy |
6,928
+4,849
| +233% | +$120K | ﹤0.01% | 2465 |
|
|
2017
Q2 | $33K | Sell |
2,079
-16,793
| -89% | -$267K | ﹤0.01% | 3137 |
|
|
2017
Q1 | $267K | Buy |
18,872
+7,659
| +68% | +$108K | ﹤0.01% | 2334 |
|
|
2016
Q4 | $148K | Buy |
11,213
+11,145
| +16,390% | +$147K | ﹤0.01% | 2442 |
|
|
2016
Q3 | $1K | Sell |
68
-422
| -86% | -$6.21K | ﹤0.01% | 3758 |
|
|
2016
Q2 | $10K | Buy |
+490
| New | +$10K | ﹤0.01% | 2989 |
|